Sphingosine 1-phosphate is a bioactive sphingolipid that regulates cell growth and suppresses programmed cell death. The biosynthesis of sphingosine 1-phosphate is catalyzed by sphingosine kinase (SK) but the mechanism by which the subcellular localization and activity of SK is regulated in response to various stimuli is not fully understood. To elucidate the origin and structural determinant of the specific subcellular localization of SK, we performed biophysical and cell studies of human SK1 (hSK1) and selected mutants. In vitro measurements showed that hSK1 selectively bound phosphatidylserine over other anionic phospholipids and strongly preferred the plasma membrane-mimicking membrane to other cellular membrane mimetics. Mutational analysis indicates that conserved Thr 54 and Asn 89 in the putative membrane-binding surface are essential for lipid selectivity and membrane targeting both in vitro and in the cell. Also, phosphorylation of Ser 225 enhances the membrane affinity and plasma membrane selectivity of hSK1, presumably by modulating the interaction of Thr 54 and Asn 89 with the membrane. Collectively, these studies suggest that the specific plasma membrane localization and activation of SK1 is mediated largely by specific lipid-protein interactions.Sphingosine 1-phosphate (S1P) 3 is a recently identified bioactive lipid that can act both extracellularly and intracellularly as a first and a second messenger, respectively (1). It has been shown that S1P is excreted into serum from platelets and binds members of the endothelial differentiation gene receptor family (S1P1-5) to activate cellular processes such as differentiation, migration, and mitogenesis (2). Intracellularly, S1P has been implicated in signaling cascades that lead to cytoskeletal changes, motility, release of intracellular Ca 2ϩ stores, and protection from apoptosis (3-6). S1P is formed from sphingosine (SPH) by sphingosine kinase (SK) and is degraded by S1P lyase and S1P phosphatases (1). In the resting state of cells, the balance between S1P formation and degradation maintains the low basal levels of S1P. However, cellular S1P levels have been shown to increase rapidly and transiently by agonists that activate SK, such as tumor necrosis factor-␣ (7, 8), platelet-derived growth factor (9), nerve growth factor (10, 11), muscarinic acetylcholine agonists (12), or phorbol esters (13,14).Two types of mammalian SKs (SK1 and SK2) have been characterized so far (15, 16), both of which are primarily cytosolic proteins. A recent study suggested that a phorbol ester, phorbol 12-myristate 13-acetate (PMA), induces the protein kinase C (PKC)-mediated phosphorylation and the localization of SK1 to the plasma membrane in human embryonic kidney (HEK) 293 cells (17), which leads to enhanced release of S1P to the media. Subsequently, it was reported that PMA and tumor necrosis factor-␣ induced the phosphorylation of Ser 225 of SK1 through the activation of mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, which resulted in pla...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.